# Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

> **NCT01150682** · — · UNKNOWN · sponsor: **Gynecologic Oncology Group** · enrollment: 865 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **GENETIC:** RNA analysis
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** enzyme-linked immunosorbent assay
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01150682
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2015-07
- **Final completion:** —
- **Target enrollment:** 865 (ESTIMATED)
- **Last updated:** 2011-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150682, "Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01150682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*